About Midwest Biomedical Accelerator Consortium (MBArC)
Missouri-Columbia, the Midwest Biomedical Accelerator Consortium (MBArC) is an NIH Research Evaluation and Commercialization Hub (REACH) program with a goal to provide funding, training, and education to academic researchers to accelerate the transition of discoveries originating from research labs into products that improve health. P
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
AI/ML, Education, Healthcare (+1 more)
Investor Type
Accelerator
Investment Focus
Focus Areas
Investment Stages